Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.

Article Details

Citation

Lee LY, Hernandez D, Rajkhowa T, Smith SC, Raman JR, Nguyen B, Small D, Levis M

Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.

Blood. 2017 Jan 12;129(2):257-260. doi: 10.1182/blood-2016-10-745133. Epub 2016 Dec 1.

PubMed ID
27908881 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs